<DOC>
	<DOC>NCT01479218</DOC>
	<brief_summary>The objective of the study is to investigate the safety, efficacy and clinical utility of the Occlutech PDA device for closure of patent ductus arteriosus of all types.</brief_summary>
	<brief_title>Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<criteria>1. Patients with a demonstrated patent ductus arteriosus 2. Female or male 3. Belonging to any ethnic group 4. Age between &gt; 6 months and 70 years 5. Body weight &gt; 6 kg &lt; 120 kg 1. Associated congenital cardiac anomalies, 2. Body weight &lt; 6 Kilograms General exclusion criteria presence of a known coagulation disorder thrombus at the position allocated for the implantation a vein thrombosis in the blood vessels chosen for the introducing system an active infection Nitinol intolerance (nickel or titanium) contrast medium intolerance patients who have a vascular system which is too small to admit the required sheath patients with pulmonary hypertension and pulmonaryvascular resistance of &gt;8 Woods Units or a lung / systemic resistance (PR/SR) of &gt;0.4.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>